UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050970
Receipt number R000058020
Scientific Title SOnographic evaLuation for Inflammatory bowel disease in Daily practice (SOLID) Study
Date of disclosure of the study information 2023/05/05
Last modified on 2025/01/24 14:05:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

SOnographic evaLuation for Inflammatory bowel disease in Daily practice (SOLID) Study

Acronym

SOLID Study

Scientific Title

SOnographic evaLuation for Inflammatory bowel disease in Daily practice (SOLID) Study

Scientific Title:Acronym

SOLID Study

Region

Japan


Condition

Condition

Ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the reliability of intestinal ultrasound (IUS), which is a non-invasive examination for assessing the disease activity of ulcerative colitis (UC), and to develop a scoring system to estimate endoscopic remission, which is a therapeutic goal of UC, based on IUS findings.

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Estimation accuracy of a scoring system based on IUS findings developed in this study (SOLID-UC index) for endoscopic remission at 6 months after starting the remission induction therapy.

Key secondary outcomes

- Intra-/inter-observer agreement rates of each sonographic parameter in each segment of the colon and in the most severely affected part of the colon
- Minimal important change of SOLID-UC index
- Correlation between changes in SOLID-UC index, in its parameters, and in endoscopic scores
- Assessment of reliability and measurement error of SOLID-UC index
- Comparison of the predictive accuracy of SOLID-UC index, partial Mayo score, Lichtiger index, and biomarkers for endoscopic remission at 6 months after remission induction treatment


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

- Subjects diagnosed with UC.
- Subjects who plan to take endoscopic examinations for assessing the disease activity of UC in daily practice.
- Subjects who are 16 years old or older when providing written consent.
- Subjects who understand, decide to take part in this study and provide written consent by themselves. Minors need consent from themselves as well as their guardians.

Key exclusion criteria

- Subjects who had total or partial colectomy or plan to take such surgery when providing written consent.
- Subjects diagnosed with proctitis or an undetermined disease type.
- Subjects with suspected concomitant colitis, e.g. infections enteritis, diverticulitis, and ischemic colitis (taking colonoscopy for examining other etiologies).
- Subjects with an emergent, critical condition of UC.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name Miyoshi

Organization

Kyorin University School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

181-8611

Address

6-20-2 Shinkawa, Mitaka-shi, Tokyo

TEL

0422-47-5511

Email

jmiyoshi@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name Miyoshi

Organization

Kyorin University School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

181-8611

Address

6-20-2 Shinkawa, Mitaka-shi, Tokyo

TEL

0422-47-5511

Homepage URL


Email

jmiyoshi@ks.kyorin-u.ac.jp


Sponsor or person

Institute

Kyorin University School of Medicine

Institute

Department

Personal name

Jun Miyoshi


Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

杏林大学医学部(東京都)、北里大学北里研究所病院炎症性腸疾患先進治療センター(東京都)、札幌医科大学附属病院(北海道)、滋賀医科大学(滋賀県)、京都大学大学院医学研究科(京都府)


Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 02 Month 07 Day

Date of IRB

2023 Year 02 Month 27 Day

Anticipated trial start date

2023 Year 05 Month 15 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This observational study aims to assess the reliability of IUS, a non-invasive examination for evaluating UC disease activity, and to develop a simple practical scoring system to predict endoscopic remission, one of today's therapeutic goals in UC.


Management information

Registered date

2023 Year 05 Month 01 Day

Last modified on

2025 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058020